Results 211 to 220 of about 81,325 (286)

Development and Validation of an Interpretable Machine‐Learning Model for Predicting Suboptimal Clinical Response After Sleeve Gastrectomy: A Multicenter Study

open access: yesMedComm, Volume 7, Issue 11, November 2026.
Suboptimal clinical response occurs in 20%–40% of patients after sleeve gastrectomy, yet reliable preoperative prediction remains challenging. We developed and externally validated an interpretable XGB model using multicenter data to identify patients at high risk of SCR.
Yuntao Nie   +22 more
wiley   +1 more source

The Conventional Cost‐Effectiveness and Distributional Cost‐Effectiveness of Semaglutide for Obesity Treatment

open access: yesObesity, Volume 34, Issue 11, Page 2146-2155, November 2026.
ABSTRACT Objective This study aimed to evaluate the conventional and distributional cost‐effectiveness of semaglutide, laparoscopic sleeve gastrectomy (LSG), and a “do nothing” option in Black and White racial subgroups. Methods A Markov simulation model was developed from a healthcare perspective over a 25‐year time horizon for Black and White adults,
Neeti S. Kulkarni   +5 more
wiley   +1 more source

Impact of Non-curative Endoscopic Submucosal Dissection on Minimally Invasive Distal Gastrectomy and on Robotic <i>Versus</i> Laparoscopic Approaches in pT1 Gastric Cancer. [PDF]

open access: yesIn Vivo
Ebihara Y   +12 more
europepmc   +1 more source

Depot‐Specific Insulin Receptor Isoform Dynamics During Human Adipose‐Derived Stem Cell Adipogenesis

open access: yesObesity, Volume 34, Issue 11, Page 2124-2134, November 2026.
Absolute quantification reveals depot‐specific insulin receptor (IR) isoform signatures in human adipose stem cells, with subcutaneous cells enriched in IRa and exhibiting greater adipogenic capacity and insulin responsiveness. The emergence of IR‐negative adipocytes highlights partially receptor‐independent pathways regulating human adipogenesis ...
Valentina Annamaria Genchi   +10 more
wiley   +1 more source

SURGELLA: A Scoping Review of Impella‐Assisted Hemodynamic Support in High‐Risk Non‐Cardiac Surgery

open access: yesArtificial Organs, Volume 50, Issue 11, Page 1532-1545, November 2026.
In selected patients with severe LV dysfunction, Impella‐supported non‐cardiac surgery may provide a temporary hemodynamic bridge to otherwise prohibitive procedures. Published evidence remains limited to a small number of highly selected cases, supporting technical feasibility rather than comparative benefit or generalizable safety.
Hussein Elghazaly   +6 more
wiley   +1 more source

Magnetic Duodeno-Ileostomy as a Conversion Procedure After Sleeve Gastrectomy: First Single-Centre Experience in Colombia. [PDF]

open access: yesObes Surg
Nassar R   +10 more
europepmc   +1 more source

scRNA‐Seq in Gastric Cancer Reveals Macrophage‐Derived C1q as a Diagnostic Marker

open access: yesCancer Science, Volume 117, Issue 11, Page 2967-2981, November 2026.
Single‐cell sequencing of GC analyzed the tumor microenvironment and discovered the C1QA+ TAMs subpopulation with immunosuppressive function. The role of C1q in the prognosis and diagnosis of GC was demonstrated through plasma and tumor tissue from the GC cohort.
Saisai Gong   +6 more
wiley   +1 more source

GLP‐1 Receptor Agonists Post‐Bariatric Surgery (GRABS) Trial: Rationale, Design and Baseline Characteristics

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 11, Page 9861-9870, November 2026.
ABSTRACT Aims No studies have investigated the synergistic effectiveness of Glucagon‐Like Peptide 1 Receptor Agonists (GLP1RAs) in patients with persistent obesity following bariatric surgery. The GLP‐1 Receptor Agonists Post‐Bariatric Surgery (GRABS) Trial aims to investigate the effectiveness of tirzepatide (TRZ) versus standard of care (SOC) after ...
J. M. Samuels   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy